VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 166 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $760 | +68.5% | 81,094 | +341.4% | 0.01% | +75.0% |
| Q2 2023 | $451 | -50.2% | 18,374 | -52.8% | 0.00% | -42.9% |
| Q1 2023 | $905 | +48.1% | 38,892 | +61.2% | 0.01% | -22.2% |
| Q4 2022 | $611 | -99.9% | 24,125 | -38.7% | 0.01% | -10.0% |
| Q3 2022 | $759,000 | -33.7% | 39,368 | -12.5% | 0.01% | -28.6% |
| Q2 2022 | $1,145,000 | -22.3% | 44,968 | -21.6% | 0.01% | -26.3% |
| Q1 2022 | $1,474,000 | +53.1% | 57,327 | +205.1% | 0.02% | +35.7% |
| Q1 2021 | $963,000 | – | 18,790 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |